GENB
Income statement / Annual
Last year (2025), Generate Biomedicines Inc's total revenue was $31.89 M,
an increase of 55.89% from the previous year.
In 2025, Generate Biomedicines Inc's net income was -$203.15 M.
See Generate Biomedicines Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
| Period Ended |
12/31/2025 |
12/31/2024 |
| Operating Revenue |
$31.89 M |
$20.46 M |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$31.89 M
|
$20.46 M
|
| Gross Profit Ratio |
1
|
1
|
| Research and Development Expenses |
$224.70 M
|
$175.31 M
|
| General & Administrative Expenses |
$42.26 M
|
$42.09 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$42.26 M
|
$42.09 M
|
| Other Expenses |
$0.00
|
$0.00
|
| Operating Expenses |
$266.96 M
|
$217.40 M
|
| Cost And Expenses |
$266.96 M
|
$217.40 M
|
| Interest Income |
$13.66 M
|
$18.12 M
|
| Interest Expense |
$1.14 M
|
$2.12 M
|
| Depreciation & Amortization |
$13.18 M
|
$15.35 M
|
| EBITDA |
-$208.49 M |
-$163.71 M |
| EBITDA Ratio |
-6.54
|
-8
|
| Operating Income Ratio |
-7.37
|
-9.63
|
| Total Other Income/Expenses Net |
$12.26 M
|
$15.77 M
|
| Income Before Tax |
-$222.80 M
|
-$181.17 M
|
| Income Before Tax Ratio |
-6.99
|
-8.86
|
| Income Tax Expense |
$163.00 K
|
$212.00 K
|
| Net Income |
-$203.15 M
|
-$173.77 M
|
| Net Income Ratio |
-6.37
|
-8.49
|
| EPS |
-4.98 |
-1.68 |
| EPS Diluted |
-4.98 |
-1.68 |
| Weighted Average Shares Out |
$50.09 M
|
$127.45 M
|
| Weighted Average Shares Out Diluted |
$50.09 M
|
$127.45 M
|
| Link |
|
|
